documents: FDA-2003-N-0196-0094

Regulatory documents from Regulations.gov including rules, proposed rules, notices, and supporting materials.

Data license: Public Domain (U.S. Government data) · Data source: Federal Register API & Regulations.gov API

This data as json

id agency_id docket_id title document_type subtype posted_date posted_year posted_month comment_start_date comment_end_date last_modified fr_doc_num open_for_comment withdrawn object_id
FDA-2003-N-0196-0094 FDA FDA-2003-N-0196 Memorandum of Meeting Minutes between FDA CDER and BASF regarding Octyl Triazone and Bemotrizinol March 19, 2015 Other Memorandum 2015-06-15T04:00:00Z 2015 6 2015-06-15T04:00:00Z   2015-06-15T17:12:42Z   0 0 0900006481b37d71

Links from other tables